(Q67723025)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729064%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729064%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Theophylline and Salbutamol Improve Pulmonary Function in Patients with Irreversible Chronic Obstructive Pulmonary Disease (English)

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

chronic obstructive pulmonary disease

10 November 2022

main subject

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

10 November 2022

author name string

P. Thomas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729064

10 November 2022

J. A. Pugsley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729064

10 November 2022

J. H. Stewart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1729064

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729064%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.elsevier.com/content/article/PII:S0012369216331427?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

https://api.elsevier.com/content/article/PII:S0012369216331427?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

10 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729064%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729064%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

160-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729064%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729064%20AND%20SRC:MED&resulttype=core&format=json

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction

10 November 2022

2

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Efficacy of inhaled metaproterenol and orally-administered theophylline in patients with chronic airflow obstruction

10 November 2022

3

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Efficacy of theophylline in "irreversible" airflow obstruction

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Effects of theophylline on breathlessness and exercise tolerance in patients with chronic airflow obstruction

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Effect of oral salbutamol and slow-release aminophylline on exercise tolerance in chronic bronchitis

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Physiologic effects of oral bronchodilators during rest and exercise in chronic obstructive pulmonary disease

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Prognosis in chronic obstructive pulmonary disease

10 November 2022

15

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Effect of Inhaled Atropine or Metaproterenol in Patients with Chronic Airway Obstruction and Therapeutic Serum Theophylline Levels

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Theophylline in chronic obstructive pulmonary disease

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

Reversing the irreversible

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1378/CHEST.101.1.160

10 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1729064%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference